Literature DB >> 16853578

A conformational dynamics study of alpha-l-Rhap-(1-->2)[alpha-l-Rhap-(1-->3)]-alpha-l-Rhap-OMe in solution by NMR experiments and molecular simulations.

Robert Eklund1, Kristina Lycknert, Peter Söderman, Göran Widmalm.   

Abstract

The conformational preference of alpha-l-Rhap-(1-->2)[alpha-l-Rhap-(1-->3)]-alpha-l-Rhap-OMe in solution has been studied by NMR spectroscopy using one-dimensional (1)H,(1)H T-ROESY experiments and measurement of trans-glycosidic (3)J(C,H) coupling constants. Molecular dynamics (MD) simulations with a CHARMM22 type of force field modified for carbohydrates were performed with water as the explicit solvent. The homonuclear cross-relaxation rates, interpreted as effective proton-proton distances, were compared to those obtained from simulation. Via a Karplus torsional relationship, (3)J(C,H) values were calculated from simulation and compared to experimental data. Good agreement was observed between experimental data and the MD simulation, except for one inter-residue T-ROE between protons in the terminal sugar residues. The results show that the trisaccharide exhibits substantial conformational flexibility, in particular along the psi glycosidic torsion angles. Notably, for these torsions, a high degree of correlation (77%) was observed in the MD simulation revealing either psi(2)(+) psi(3)(+) or psi(2)(-)psi(3)(-) states. The simulations also showed that non-exoanomeric conformations were present at the phi torsion angles, but to a limited extent, with the phi(3) state populated to a larger extent than the phi(2) state. Further NMR analysis of the trisaccharide by translational diffusion measurements and (13)C T(1) relaxation experiments quantified global reorientation using an anisotropic model together with interpretation of the internal dynamics via the "model-free" approach. Fitting of the dynamically averaged states to experimental data showed that the psi(2)(+)psi(3)(+) state is present to approximately 49%, psi(2)(-) psi(3)(-) to approximately 39%, and phi(3) (non-exo) to approximately 12%. Finally, using a dynamic and population-averaged model, (1)H,(1)H T-ROE buildup curves were calculated using a full relaxation matrix approach and were found to be in excellent agreement with experimental data, in particular for the above inter-residue proton-proton interaction between the terminal residues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16853578     DOI: 10.1021/jp053198o

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  7 in total

1.  Sucrose in aqueous solution revisited, Part 2: adaptively biased molecular dynamics simulations and computational analysis of NMR relaxation.

Authors:  Junchao Xia; David A Case
Journal:  Biopolymers       Date:  2011-11-05       Impact factor: 2.505

2.  Searching and optimizing structure ensembles for complex flexible sugars.

Authors:  Junchao Xia; Claudio J Margulis; David A Case
Journal:  J Am Chem Soc       Date:  2011-09-08       Impact factor: 15.419

3.  Molecular dynamics and NMR spectroscopy studies of E. coli lipopolysaccharide structure and dynamics.

Authors:  Emilia L Wu; Olof Engström; Sunhwan Jo; Danielle Stuhlsatz; Min Sun Yeom; Jeffery B Klauda; Göran Widmalm; Wonpil Im
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

4.  Methyl 4-O-benzyl-α-l-rhamno-pyrano-side.

Authors:  Robert Pendrill; Lars Eriksson; Göran Widmalm
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-04-16

5.  Analysis and validation of carbohydrate three-dimensional structures.

Authors:  Thomas Lütteke
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20

6.  Methyl α-l-rhamnosyl-(1→2)[α-l-rhamnosyl-(1→3)]-α-l-rhamnoside penta-hydrate: synchrotron study.

Authors:  Lars Eriksson; Göran Widmalm
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-27

Review 7.  Structural glycobiology: a game of snakes and ladders.

Authors:  Mari L DeMarco; Robert J Woods
Journal:  Glycobiology       Date:  2008-04-04       Impact factor: 4.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.